We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$776M
AUM Growth
-$138M
(-15%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-22.7%
Top 10 Holdings %
Top 10 Hldgs %
36.6%
Holding
70
New
9
Increased
23
Reduced
28
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$19M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
+$18.6M |
| 3 |
Gilead Sciences
GILD
|
+$18M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$17.4M |
| 5 |
Molina Healthcare
MOH
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$25.7M |
| 2 |
DexCom
DXCM
|
+$24.4M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$20M |
| 4 |
Viatris
VTRS
|
+$19.2M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 92.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Accuray
ARAY
$29.8M
| $2.75M | 0.35% |
687,547
+99,200
| +17% | +$426K |
|
|
NXTM
52
DELISTED
NxStage Medical Inc.
NXTM
| $2.72M | 0.35% |
98,579
-251,130
| -72% | -$6.7M |
|
|
DBVT
53
DBV Technologies
DBVT
$862M
| $2.24M | 0.29% |
5,280
-12,635
| -71% | -$5.41M |
|
|
FSTX
54
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.08M | 0.27% |
30,846
+2,721
| +10% | +$156K |
|
55
Insmed
INSM
$23.2B
| $1.95M | 0.25% |
62,399
-83,400
| -57% | -$1.59M |
|
56
Illumina
ILMN
$27.9B
| $1.86M | 0.24% |
9,612
-7,710
| -45% | -$1.44M |
|
|
OBSV
57
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $1.73M | 0.22% |
212,831
| – | – |
|
58
Dr. Reddy's Laboratories
RDY
$10.4B
| $1.63M | 0.21% |
228,980
+133,655
| +140% | +$961K |
|
|
TRIL
59
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.21M | 0.16% |
234,248
+50,976
| +28% | +$240K |
|
60
TG Therapeutics
TGTX
$8.26B
| $1.19M | 0.15% |
100,366
+19,100
| +24% | +$218K |
|
|
CMTA
61
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $512K | 0.07% |
+30,313
| New | +$495K |
|
|
SRRA
62
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $313K | 0.04% |
5,042
| – | – |
|
|
63
DexCom
DXCM
$29.2B
| – | – |
-1,333,364
| Closed | -$24.4M |
|
64
Intuitive Surgical
ISRG
$125B
| – | – |
-148,203
| Closed | -$15.4M |
|
|
SAGE
65
DELISTED
Sage Therapeutics
SAGE
| – | – |
-12,199
| Closed | -$972K |
|
|
66
Teva Pharmaceuticals
TEVA
$36.1B
| – | – |
-602,279
| Closed | -$20M |
|
|
67
Viatris
VTRS
$19.8B
| – | – |
-495,804
| Closed | -$19.2M |
|
|
ARAV
68
DELISTED
Aravive, Inc. Common Stock
ARAV
| – | – |
-17,460
| Closed | -$1.83M |
|
|
ENDP
69
DELISTED
Endo International plc
ENDP
| – | – |
-820,699
| Closed | -$9.17M |
|
|
IMDZ
70
DELISTED
Immune Design Corp.
IMDZ
| – | – |
-168,300
| Closed | -$1.64M |
|
Similar funds
RIP
CCM
LFWA
FWA
CF
WIM
MW
AFC
Sectoral Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, Sectoral Asset Management held 70 positions worth $776M, down 15% from $914M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Sectoral Asset Management withdrew a net $176M in Q3 2017, closing 8 positions and reducing 28 holdings. Its most notable exit was DexCom, an estimated $24.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 94% a quarter earlier.
Against the trend, Sectoral Asset Management opened a new position in UnitedHealth worth $19.2M.
- Sectoral Asset Management's largest Q3 2017 buy was UnitedHealth: 98,205 shares worth $19.2M.
- Sectoral Asset Management added most to Clovis Oncology, Inc. in Q3 2017, an estimated $17.4M increase.
- Sectoral Asset Management's biggest Q3 2017 reduction was Merck, cutting an estimated $25.7M.
- Sectoral Asset Management fully exited DexCom in Q3 2017, selling an estimated $24.4M.
- Sectoral Asset Management's ten largest holdings make up 37% of its $776M portfolio in Q3 2017.
- Sectoral Asset Management opened 9 new positions and closed 8 in Q3 2017.
- Sectoral Asset Management's portfolio value fell 15% quarter-over-quarter to $776M.
Based on Sectoral Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.